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Background: Human infections with Serratia spp. are generally limited to Serratia marcescens and the Serratia
liquefaciens complex. There is little data regarding the infections caused by the remaining Serratia spp., as
they are seldom isolated from clinical specimens.
Methods: In this health care setting in Kathmandu, Nepal routine blood culture is performed on all febrile
patients with a temperature >38°C or when there is clinical suspicion of bacteremia. During 2015 we atypic-
ally isolated and identiﬁed several Serratia spp. We extracted clinical data from these cases and performed
whole genome sequencing on all isolates using a MiSeq system (Ilumina, San Diego, CA, USA).
Results: Between June and November 2015, we identiﬁed eight patients with suspected bacteremia that pro-
duced a positive blood culture for Serratia spp., six Serratia rubidaea and ﬁve Serratia marcescens. The S. rubi-
daea were isolated from three neonates and were concentrated in the neonatal intensive care unit between
June and July 2015. All patients were severely ill and one patient died. Whole genome sequencing conﬁrmed
that six Nepalese S. rubidaea sequences were identical and indicative of a single-source outbreak.
Conclusions: Despite extensive screening we were unable to identify the source of the outbreak, but the
inferred timeline suggested that these atypical infections were associated with the aftermath of two massive
earthquakes. We speculate that deﬁcits in hygienic behavior, combined with a lack of standard infection con-
trol, in the post-earthquake emergency situation contributed to these unusual Serratia spp. outbreaks.
Keywords: bloodstream infections, natural disaster infection outbreak, Serratia marcescens, Serratia rubidaea, Serratia spp.
Introduction
The Gram-negative bacterial genus Serratia is found within the
broad Enterobacteriaceae family and is currently differentiated
into 10 species.1 Human infections with Serratia are not as com-
mon as with more virulent members of the Enterobacteriaceae
(e.g., Salmonella, Klebsiella, Escherichia coli), but when they do
arise they are largely associated with Serratia marcescens and
the Serratia liquefaciens complex, which includes S. liquefaciens,
Serratia proteomaculans and Serratia grimesii.1,2 There is little
data regarding the infections caused by the remaining Serratia
species, as they are seldom isolated from clinical specimens.2
S. marcescens is the primary species within the Serratia genus
associated with disease. The organism can be isolated from vari-
ous clinical specimens (e.g., blood, tracheal aspirates, urine)
when associated with infection, and health care–related out-
breaks of S. marcescens are well described.3–5 S. marcescens
thrives in moist environments, which can include intravenous
solutions, indwelling intravenous catheters, soaps and disinfec-
tants, all of which have been described as the source of
© The Author(s) 2018. Published by Oxford University Press on behalf of Royal Society of Tropical Medicine and Hygiene.
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outbreaks.4–7 Notably, although some cases have been reported,
S. marcescens rarely causes invasive community-acquired infec-
tions among nonimmunocompromised individuals.8,9
Serratia rubidaea is a less well-described member of the
genus and is chieﬂy found in soil, water and food. The isolation
of this organism from clinical specimens is rare,10,11 but it can
cause opportunistic infections in severely ill patients receiving
broad-spectrum antimicrobials or those that have undergone
surgery or other invasive procedures.3,10,12–14 When identiﬁed in
clinical specimens, S. rubidaea is largely isolated from respiratory
tract samples, skin wounds, feces and bile.
Materials and methods
Patan Hospital is a 450-bed general hospital that serves the
local population in the Lalitpur area of the central Kathmandu
valley. All neonates in which the Serratia infections arose were
among those neonates who were born in Patan Hospital; all
other patients with Serratia infections had presented with fever
to the emergency department of Patan Hospital. All procedures
were reviewed and approved by the institutional review board
(OxTREC 24-16) as well as the Nepal Health Research Council
(278/2015).
Blood cultures are performed routinely on all febrile patients
with a temperature >38°C or when there is clinical suspicion of
bacteremia. For blood cultures in pediatric patients, 3–5mL of
venous blood was drawn and inoculated into BACTEC Peds Plus
aerobic bottles following the manufacturer’s recommendations
(Becton Dickinson, Franklin Lakes, NJ, USA). All inoculated bottles
were incubated at 37°C in a BACTEC 9050 analyzer for 7 days15
or until ﬂagged growth in the automated system. Organisms
were identiﬁed by standard methods, including API20E identiﬁ-
cation kits (Bio-Mérieux, Craponne, France). Antimicrobial sus-
ceptibility testing was performed at the time of isolation by the
modiﬁed Kirby–Bauer disc diffusion method. Zone size interpre-
tations were performed following the Clinical and Laboratory
Standards Institute guidelines. The organisms were tested
against 15 antimicrobials (Table 1).
Genomic DNA was extracted using the Wizard genomic DNA
puriﬁcation kit (Promega, Madison, WI, USA) and sequenced on
a MiSeq system (Ilumina, San Diego, CA, USA). A total of 300
base paired end reads were subjected to de novo assembly
using Velvet16 and annotated using Prokka.17 The resulting pan-
genome, consisting of 1945 genes, was generated using Roary18
with the 11 novel genome sequences from this study and 11
Serratia spp. sequences accessed from the National Center for
Biotechnology Information. Single-nucleotide polymorphism
(SNP) sites were extracted from a multi-FASTA alignment of
the core genomes of the 22 sequences18 and a maximum likeli-
hood phylogenetic tree was generated using RAxML using a
Generalized Time Reversal model with a gamma correction and
100 bootstrap replicates.19 Antimicrobial resistance genes were
identiﬁed using ARIBA software20 using the Comprehensive
Antibiotic Resistance Database.21 Results were viewed in
Phandango.22
Environmental sampling for the neonatal intensive care unit
(NICU) was performed after the identiﬁcation of the ﬁrst Serratia
spp. in the blood. Swab samples were taken from the air
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conditioner ﬁlters and linings, window linings, sink surfaces, medi-
cine trolley, weighing machine, door handles and phone sets. All
swabs were plated on MacConkey and blood agar and incubated
for 48 h at 37°C. Bacterial isolates were identiﬁed by standard
methods, including API20E identiﬁcation kits (Bio-Mérieux).
Results
Between June and November 2015, 11 Serratia spp. (6 S. rubi-
daea and 5 S. marcescens) were isolated from blood cultures in
this health care facility (Table 1). In comparison, Serratia spp.
had not been isolated in this hospital between 1992 and 2016.
The six S. rubidaea samples (2167, 2196, 2188, 2195, 2208 and
2199) were isolated in June and July in the NICU from three chil-
dren (some repeat samples) born at the hospital in the preceding
days. The ﬁve S. marcescens samples (2301, 2313, 2314, 2315 and
2280) were isolated from ﬁve patients from either the pediatric
ward, the NICU or the emergency department between September
and November (Table 1). All ﬁve patients with S. marcescens bacter-
emia presented to the hospital with high-grade fever (>39°C) of >3
d. The blood samples taken on the day of hospital admission (day
1) produced a positive culture for S. marcescens, suggesting that all
infections were community acquired. Available medical records did
not identify any notable risk factors for infection and reported the
death of one of the patients (Table 1).
Given the rarity and the temporal clustering of the S. rubidaea
cases, we extracted the hospital notes from the three patients
with these infections. Patient 1 (2167) was associated with a
female born via a vaginal breech delivery at 29 weeks of gesta-
tion. The mother had had no complications during pregnancy,
but the child had a low birth weight (1.1 kg), with APGAR scores
of 2/10 and 4/10 at 1 and 5 min after birth, respectively.
Resuscitation was performed and she was intubated. The child
was transferred immediately to the NICU, where she was given
respiratory support through continuous positive airway pressure
(CPAP). On admission to the NICU her heart rate was 165 bpm
and her blood pressure was 55/28 mmHg. A blood culture was
requested on day 1 in the NICU and she was empirically admi-
nistered ampicillin and amikacin for 5 d. The results of the pri-
mary blood culture were negative, but due to deterioration in
her condition and the development of fever on day 5 she was
administered meropenem and colistin. There was no clinical
improvement and a blood culture was repeated on day 17,
which resulted in the isolation of S. rubidaea. Antimicrobials
meropenem and colistin were continued, but due to the lack of
clinical improvement, a repeat blood culture was performed on
days 20, 24 and 26, all of which were negative. As the fever had
not subsided, the child was switched to oﬂoxacin and amikacin.
The fever still did not subside and on day 37 a blood culture
was again performed, resulting in the isolation of S. rubidaea
that was resistant to amoxicillin, chloramphenicol, ampicillin-
sulbactam and colistin but susceptible to other available antimi-
crobials (Table 1). The neonate was placed on a combination of
vancomycin and meropenem. The fever began to subside on
day 41 and on day 44, after a sterile blood culture, the infant
was transferred to the nursery. The infant remained in the nur-
sery until day 92 of life, when she had a body weight of 1.48 kg
and was discharged.
After this primary case of S. rubidaea bacteremia we con-
ducted rigorous environmental sampling of the NICU, however,
the culture results were inconclusive. As the procedure of fumi-
gation can reach all spaces and eliminate a host of bacteria
with long-lasting effects, the hospital, according to available
infection control guidelines, decided to perform the procedure in
the NICU. Formaldehyde fumigation of the NICU was performed
on 19 June, but patient 2 (2188) was identiﬁed on 29 June—a
female newborn delivered after an emergency cesarean at 36
weeks. The mother was hospitalized with preeclampsia and
intrauterine growth retardation during the third trimester. The
neonate was of low birth weight (1 kg), was in respiratory dis-
tress (respiratory rate 36) and admitted to the NICU, where she
was given respiratory support with CPAP. The child was treated
empirically with ampicillin and amikacin for 5 d. On the third
day after delivery, an endocervical swab of the mother returned
growth of Klebsiella pneumoniae that was resistant to amoxicil-
lin, cefotaxime and cotrimoxazole but susceptible to ciproﬂoxa-
cin and chloramphenicol. The neonate developed fever on day 9
and was prescribed meropenem, colistin, aminophylline and ﬂu-
conazole. There was no improvement in the condition of the
child and on day 17 in the NICU, a blood culture (2195) was
positive for S. rubidaea that was resistant to amoxicillin, chlor-
amphenicol, ampicillin-sulbactam and colistin but susceptible to
other available antimicrobials (Table 1). The neonate had inter-
mittent CPAP support and on day 19 she was placed on a venti-
lator. An additional blood culture (2208), performed on day 26
in the NICU, remained positive for S. rubidaea and had an identi-
cal antimicrobial susceptibility pattern as the isolate recovered
from the blood culture on day 17. Treatment was switched to
cefotaxime and oﬂoxacin for 5 d. The infant remained febrile
and a blood culture performed on day 33 returned S. rubidaea
that exhibited resistance to cefotaxime with the same suscepti-
bility proﬁle as the primary bloodstream isolate. The neonate
was switched to meropenem, amikacin and oﬂoxacin. The fever
began to subside on day 34, but S. rubidaea was again isolated
from a blood culture on day 37. Despite the continued isolation
of S. rubidaea from blood, the neonate improved and, once
afebrile (day 40), she was transferred to the nursery where she
began to gain weight. On reaching a body weight of 1.8 kg (day
75 of life) she was discharged.
A third patient (2199) on 7 July suggested either inadequate
fumigation of the NICU or human-to-human contact transmis-
sion. The neonate was born through assisted vaginal delivery at
28 weeks of gestation. An sonogram performed 1 month prior
to delivery suggested a normal pregnancy with a fundal poster-
ior placenta. The mother had a history of primary infertility and
had conceived after a dilation and curettage surgery. The
mother also had pelvic discharge during the third trimester and
a urine culture resulted in the isolation of K. pneumoniae that
was resistant to ampicillin, cefotaxime, cotrimoxazole, nitrofur-
antoin and nalidixic acid. The premature neonate was a male of
low birth weight (1.1 kg), with an APGAR score of 7/10 and 8/10
at 1 and 5 min after birth, respectively. After birth, the neonate
developed secondary apnea; bagging was performed for two
cycles and then he was intubated and transferred to the NICU.
He was administered ampicillin, amikacin and cefotaxime after
a blood sample had been collected for microbiological culture.
On day 2, the infant went into septic shock, with a heart rate of
Transactions of the Royal Society of Tropical Medicine and Hygiene
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172 bpm and a blood pressure of 44/15 mmHg. A blood culture
performed on day 1 was positive for K. pneumoniae and the iso-
late exhibited an identical antimicrobial susceptibility pattern as
the organism previously isolated from the mother. The infant was
administered dopamine and a ﬂuid bolus on two occasions and
was treated with colistin and meropenem. The neonate remained
febrile and the umbilical venous catheter (UVC) tip along with a
repeat blood sample was sent for microbiological culture on day
14. Both cultures were positive for S. rubidaea that was resistant
to cefotaxime, tigecycline, chloramphenicol and cotrimoxazole
but was susceptible to other available antimicrobials (Table 1).
The neonate remained febrile and was unable to gain weight. On
day 27, due to his prematurity and deranged coagulation sec-
ondary to septicemia, he developed a grade IV intraventricular
hemorrhage with periventricular leukomalacia and bilateral
hydrocephalus. It was decided that ventilator support would be
withdrawn and the child subsequently died.
Extensive infection control precautions were taken. Rigorous
hand hygiene was observed whereby hands and equipment were
cleaned and disinfected on the way into the patient’s room and
Figure 1. The phylogenetic relationship of Serratia associated with bacteremia in Nepal. Maximum likelihood phylogenetic tree generated using
RAxML of the 11 novel Nepalese Serratia sequences and the reference genomes of S. odorifera_4582 (DBY01000000), S. rubidaea_112 (CP014474),
S. fonticola_UTAD54 (AUZV01000000), S. fonticola_4576 (CP011254.1), S. marcescens WW4 (CP003959), S. marcescens Db11 (HG326223),
S. plymuthica_4RX13 (CP006250), S. plymuthica_AS9 (CP002773), S. grimesii_A2 (JGVP00000000), S. proteomaculans_568 (CP000826) and S. liquefa-
ciens (CP011303). Branches are numbered with bootstrap values and the scale corresponds to the number of substitutions per site.
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on the way out again. Environmental hygiene was observed
through continuous cleaning and disinfection. The mothers of the
neonates were included in the infection prevention protocols,
which helped in the maintenance of a clean and sanitary environ-
ment. Neonates who came for admission into the NICU were
screened and all microbiological data were surveyed to ensure
that there were no further outbreaks. Following these precau-
tions, no further cases of Serratia spp. were reported.
To add further context to the isolation of these organisms, the
six S. rubidaea and ﬁve S. marcescens samples were subjected to
whole genome sequencing. The phylogenetic structure of 22
Serratia sequences (including reference sequences) conﬁrmed the
subspecies classiﬁcation generated using conventional biochemical
testing, segregating the S. rubidaea and S. marcescens into distinct
lineages (Figure 1). The six Nepalese S. rubidaea sequences were
identical (indicative of a single-source outbreak) and clustered
alongside the sequence of S. rubidaea isolated from a patient in
China,14 varying by 298 SNPs from this sequence. The S. marcescens
sequences clustered alongside the previously sequenced Db1123
and WW424 organisms. In a comparable fashion to the S. rubidaea,
we observed that four of the S. marcescens organisms were all
identical, and again likely part of an isolated outbreak in the com-
munity. Notably, S. marcescens 2314 was distantly related to the
other organisms, sitting adjacent to the two reference genomes. All
11 of the Serratia isolates were phenotypically resistant to amoxicil-
lin, ampicillin-sulbactam, chloramphenicol and colistin. However,
genotypic analysis found only an aac(6′)Ic gene, which was located
on the chromosome and confers resistance to aminoglycosides;
isolates were found to be susceptible to gentamicin (Table 1). This
lack of genotype support for the antimicrobial susceptibility was
not surprising, as Serratia spp. are intrinsically resistant to multiple
antimicrobials, including colistin and some broad-spectrum β-lac-
tams, and the resistance gene content may not be associated with
in vitro phenotypic observations.2,25
Discussion
All these cases of Serratia spp. presented within a few weeks of
two massive earthquakes, which occurred on 25 April (7.8
Richter) and 12 May (7.3 Richter), with continuous aftershocks
reaching magnitudes of up to 6.7 Richter. It is known that nat-
ural disasters, including earthquakes, often lead to an increase
in speciﬁc infectious diseases.26 The physical structure of the
hospital was severely damaged during these earthquakes and
various hospital facilities, including surgery and obstetric birthing
centers, were temporarily relocated to tents outside of the hos-
pital for up to 4 months after the earthquake. All the neonates
with S. rubidaea bacteremia had been born in these tents and
were likely exposed to a higher infection risk in the postearth-
quake disorder. All of the cases were low birth weight, prema-
ture neonates, which are generally predisposed to acquiring
infections. Considering the time span of the S. rubidaea infec-
tions and their genetic relatedness, we surmise that these cases
were an atypical outbreak restricted to the NICU. The ﬁrst neo-
nate was likely infected through a reservoir in the soil or through
the mother during delivery in the tents, with then successive
cases being infected within the NICU during treatment proce-
dures such as intubation or catheterization or simply through
hand transmission from the health care providers. The pathogen
will often lodge ﬁrst in the gastrointestinal tract and will then
translocate to other sites such as the urinary or respiratory tracts.
From there the organisms were likely picked up in the blood fol-
lowing constant seeding. Generally in a NICU the source of an
outbreak of infection with Gram-negative bacilli is a fairly con-
stant one, such as the water supply, but it seems from the evi-
dence here that the mothers were a more likely the source of the
S. rubidaea and that the labor wards were most likely involved.
Comparatively, the S. marcescens cases presented to the hospital
with presentations indicative of community-acquired infections,
which is again atypical for cases of S. marcescens. Comparable to
the S. rubidaea isolates, the majority of the S. marcescens were
genetically identical. These data therefore suggest that these cases
were an isolated community outbreak. We were unable to conﬁrm
an epidemiological association between cases due to the lack of
post-earthquake follow-up data.
Our observations outline atypical epidemiological observa-
tions of Serratia spp. infections in a hospital setting in the post–
2015 earthquake period in Kathmandu. The earthquakes
resulted in substantial disruption of medical care and interven-
tions, which limited our outbreak investigation, as we were
unable to carry out environmental sampling. Additionally, infec-
tion control and surveillance for nosocomial infections are not
well established in Nepal. Rapid hygienic interventions in the
hospital and preemptive screening of patients are known to be
effective in overcoming hospital outbreaks. We consider that the
deﬁcits in hygienic behavior combined with the lack of standard
infection control measures during emergency conditions likely
contributed to this outbreak.
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